Advanced health intelligence ltd: shareholder update - fda and stellenbosch study

South perth, australia--(newsfile corp. - july 5, 2023) - advanced health intelligence ltd (asx : ahi)  (nasdaq: ahi) ("advanced health intelligence", "ahi" or the "company") shareholder update regarding technology progress and stellenbosch university study. we are delighted to provide a comprehensive update on the latest developments at advanced health intelligence, specifically focusing on our ground-breaking smartphone-based biometric health assessment (bha).
AHI Ratings Summary
AHI Quant Ranking